Xtant Medical Holdings Inc
XTNT
Get informed when a big investor buys or sells
+ FollowMarket Cap$48.5M
Close$
$1.38
321.8% upside
Current Fair Value
321.8% upsideUndervalued by 321.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $48.50 Million |
|---|---|
| Enterprise Value | $64.74 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.04 |
| Beta | -0.15 |
| Outstanding Shares | 140,258,667 |
Return
| Return on Equity | -27.83% |
|---|---|
| Return on Assets | -13.98% |
| Return on Invested Capital | -13.95% |
Valuation & Multiples
| P/E Ratio | -4.2 |
|---|---|
| PEG | 1.15 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.59 |
| Enterprise Value to EBIT | -9.33 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.4 |
| Debt to Equity | 0.65 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 12, 2026
EPS Estimate
$-0.02
Average shareholder expectationRevenue Estimate
$24.88 M
Average shareholder expectationNext Earnings Call
Expected Date
November 6, 2026
EPS Estimate
$-0.02
Average shareholder expectationRevenue Estimate
$26.27 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 57.22%▼ 0.52% |
|---|---|
| Total Invested | $33.78M▼ 25.01% |
| Investors Holding | 32▼ 2.00% |
ESG Score
No data
About Xtant Medical Holdings Inc
CEO: Sean Browne